Acosta-Garduño F, Guillen-Rojas R

Language: Spanish
References: 17
Page: 21-27
PDF size: 202.61 Kb.

Text Extraction

No abstract.

REFERENCES

1. Zamorano JL, Lancellotti P, Rodriguez MD, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J. 2016;37:2768-2801.

2. Prisco D, D’Elios MM, Cenci C, Ciucciarelli L, Tamburini C. Cardiovascular oncology: a new discipline inside internal medicine? Intern Emerg Med. 2014;9:359-364.

3. Chan J, Rosenfeldt F, Chaudhuri K, Marasco S. Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality. Heart Lung Circ. 2012;21:255-259.

4. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing non cardiac surgery. Circulation. 2014;130:2215-2245.

5. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest of Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e326S-50S.

6. Neugut AI, Lebwohl B. Is the prevalence of colorectal neoplasm higher in patients with coronary artery disease? Nat Clin Pract Oncol. 2008;5:248-249.

7. Yusuf WS, Razeghi P, Yeh ET. The diagnosis and management of cardiovascular disease in cancer patients. Curr Probl Cardiol. 2008;33:163-196.

8. Saxena P, Tam RK. Combined off-pump coronary artery bypass surgery and pulmonary resection. Ann Thorac Surg. 2004;78:498-501.

9. Chan AO, Jim MH, Lam KF, Morris JS, Siu DC, Tong T, et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA. 2007;298:1412-1419.

10. Available in: nwww.euroscore.org/calc.htm, riskcalculator.facs.org

11. Patient and caregiver resources: cardiotoxicity. National Comprehensive Cancer Network website. Available in: http://www.nccn.org/patients/resources/life_with_cancer/managing_symptoms/cardiac_toxicity.aspx.

12. Barash PG. Chemotherapy agents with know cardiovascular side effects and their implications. J Cardiothorac Vasc Anesth. Epub. 2016

13. McGale P, Darby SC, Hall P, Adolfsson J, Bengtsson NO, Bennet AM, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol. 2011;100:167-175.

14. Cella L, Liuzzi R, Conson M, Torre G, Caterino M, De Rosa N, et al. To Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin’s lymphoma. Radiother Oncol. 2011;101:316-321.

15. Shapiro LM. Cardiac tumours: diagnosis and management. Heart. 2001;85:218-222.

16. Dujardin KS, Click RL, Oh JK. The role of intraoperative transesophageal echocardiography in patients undergoing cardiac mass removal. J Am Soc Echocardiogr. 2000;13:1080-1083.

17. Ferraris V, Brown J, Despotis G, Hammon J, Reece B, Saha S, et al. 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. Ann Thorac Surg. 2011;91:944-982.